sameAs
National mass drug administration costs for lymphatic filariasis eliminationGlobal eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmesHow to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan AfricaLymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmissionNeglected tropical diseases and the millennium development goals: why the "other diseases" matter: reality versus rhetoric.Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities.A case for South-South collaboration for trachoma elimination.Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system.DILEMMAS OF COMMUNITY-DIRECTED MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS CONTROL: A QUALITATIVE STUDY FROM URBAN AND RURAL TANZANIA.Can mobile phones help control neglected tropical diseases? Experiences from Tanzania.Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.Urban schistosomiasis and soil transmitted helminthiases in young school children in Dar es Salaam and Tanga, Tanzania, after a decade of anthelminthic intervention.Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa.Immunoepidemiology of Wuchereria bancrofti infection in two East African communities: antibodies to the microfilarial sheath and their role in regulating host microfilaraemia.The role of community participation for sustainable integrated neglected tropical diseases and water, sanitation and hygiene intervention programs: A pilot project in Tanzania.Biosocial Determinants of Persistent Schistosomiasis among Schoolchildren in Tanzania despite Repeated Treatment
P50
Q28469337-30D5F418-84C5-49DE-A8C5-A933BBD3E4F5Q28473359-14512BCF-ACB8-4002-8185-C7FACC7A98CFQ28474748-2D25BA92-4EBB-47F9-9BC2-70A6B77C4574Q34839765-A66282AA-43DF-4B0F-9C40-FDCB556A40C5Q35735934-E991D33D-804D-4A10-85A5-B7698CEAF487Q36313926-8D17B963-34B7-472B-9C18-3281E60479B3Q37684389-28594B83-5582-43A0-98C1-329A8B037960Q38678870-7750652C-1F07-4F71-ADDC-C1A432B11B4BQ39139270-86EF7D92-4949-44F5-BA6D-DD2CFC8E0C17Q39202036-D2FFE9C3-C5AE-4861-9D22-E6166C43C6D3Q40144237-B01E05B3-DF1D-4191-BE3D-A567F67A372EQ40168902-137E08F4-7B74-4413-8818-997F28FA47AEQ43950186-A256ED6B-8561-4E1F-BA05-76BEE2B06E73Q44141217-E09742E0-16A0-4CB7-8ED5-A2C0AD205B59Q51744848-5F92B5FA-169B-4607-B89B-E9C5D7172F40Q57151155-BFF5B55B-0A04-4641-B804-E37B382F12B3
P50
description
Tanzanian health administrator
@en
dokter asal Tanzania
@id
femme médecin tanzanienne
@fr
tansanische Politikerin
@de
طبيبة تنزانية
@ar
name
Mwele Ntuli Malecela
@ast
Mwele Ntuli Malecela
@en
Mwele Ntuli Malecela
@es
Mwele Ntuli Malecela
@fr
Mwele Ntuli Malecela
@ga
Mwele Ntuli Malecela
@nl
Mwele Ntuli Malecela
@sl
Mwele Ntuli Malecela
@sw
Mwele Ntuli Malecela
@vi
type
label
Mwele Ntuli Malecela
@ast
Mwele Ntuli Malecela
@en
Mwele Ntuli Malecela
@es
Mwele Ntuli Malecela
@fr
Mwele Ntuli Malecela
@ga
Mwele Ntuli Malecela
@nl
Mwele Ntuli Malecela
@sl
Mwele Ntuli Malecela
@sw
Mwele Ntuli Malecela
@vi
altLabel
Mwelecele Ntuli Malecela
@en
prefLabel
Mwele Ntuli Malecela
@ast
Mwele Ntuli Malecela
@en
Mwele Ntuli Malecela
@es
Mwele Ntuli Malecela
@fr
Mwele Ntuli Malecela
@ga
Mwele Ntuli Malecela
@nl
Mwele Ntuli Malecela
@sl
Mwele Ntuli Malecela
@sw
Mwele Ntuli Malecela
@vi
P106
P2031
2017-01-01T00:00:00Z
P21
P27
P31
P569
1963-03-26T00:00:00Z